Setting up a medical device distribution business in Kenya means clearing two separate regulatory gates before a single unit reaches a hospital or pharmacy shelf: authorisation for the product itself, and a licence for the premises that will store and move it. Distributors who treat these as one step, or assume that registering the device is enough on its own, run into delays that a proper sequencing would have avoided.
What Counts as a Medical Device Under Kenyan Law
The Pharmacy and Poisons Act defines a medical device broadly: any instrument, apparatus, implement, machine, appliance, implant, in vitro reagent or calibrator, software, material, or similar article intended for diagnosis, prevention, monitoring, or treatment, provided it does not achieve its primary action through pharmacological, immunological, or metabolic means. That last qualifier is what separates a device from a medicine for regulatory purposes, and it is why a product that looks like a straightforward piece of equipment, an infusion pump, a diagnostic reagent kit, a surgical implant, still falls squarely within the Pharmacy and Poisons Board’s jurisdiction rather than outside it.
The Board classifies devices by risk, from Class A (lowest risk) to Class D (highest risk), and the classification a product receives shapes how much technical documentation its registration requires. A distributor bringing in Class A consumables faces a materially lighter file than one bringing in Class D implantable devices, so working out the classification early is worth doing before committing to a product line.
Product Registration: Market Authorisation
Before a device can be marketed or distributed in Kenya, it needs Market Authorisation from the PPB. For medical devices specifically, this means submitting a technical file covering the product’s design, intended use, safety data, and manufacturing practices, along with labelling and any claims the distributor intends to make about the device’s performance. This is a product-level approval, tied to the specific device and its manufacturer, not a general licence to trade in devices as a category.
A common mistake among new distributors is assuming that a device already registered in its country of origin, the United States, the European Union, or elsewhere, can be sold in Kenya on the strength of that foreign approval alone. It cannot. The PPB requires its own registration process regardless of what authorisation the device already carries abroad, though evidence of established regulatory approval elsewhere is normally submitted as part of the Kenyan technical file and can streamline the Board’s review.
Premises Licensing and the Wholesale Dealer’s Licence
Registering the product is only half the requirement. The business itself, the entity storing and distributing the device, needs a separate Premises Licence from the PPB, and where the distributor is dealing in poisons or scheduled products alongside devices, a Wholesale Dealer’s Licence as well. Under the Pharmacy and Poisons Act, a wholesale dealer’s licence requires a registered pharmacist to oversee the operation, and the licence holder must be resident in Kenya. Each premises requires its own licence rather than one licence covering multiple sites, and the licence runs on an annual cycle expiring on 31 December, which means renewal has to be planned for rather than left until the business is already trading without cover.
Distributors who set up storage or distribution premises without first securing this licence are operating outside the law from day one, even if their product registrations are otherwise in good order. The two approvals, product and premises, need to be pursued in parallel, not sequentially, if a launch timeline is going to hold.
Good Storage and Distribution Practice
The PPB’s Good Storage and Distribution Practices guidelines set the operational standard a licensed distributor is expected to meet on an ongoing basis, covering warehouse conditions, temperature control for products that need it, stock rotation, traceability records, and how a recall is to be handled if one is issued. These are not a one-time application requirement; they are inspected against, and the Board’s 2026 enforcement activity, which included dozens of premises closures for non-compliance in the past year, shows the standard is actively checked rather than assumed.
A distributor building out a warehouse or logistics chain for medical devices should treat these guidelines as the operating manual for the business, not a document to file away once the premises licence is granted.
Penalties for Getting This Wrong
The consequences for operating outside this framework are not trivial. Carrying on an unlicensed pharmacy or medical device business can attract up to three years’ imprisonment, and operating unlicensed premises specifically carries a fine of up to KES 1,000,000 or up to three years’ imprisonment, in addition to the immediate commercial cost of stock being seized or a facility being closed pending compliance.
How We Can Help
Clay & Associates Advocates advises medical device distributors, importers, and manufacturers on PPB product registration, premises and wholesale dealer licensing, and ongoing regulatory compliance. Our guide to market entry for foreign pharmaceutical companies covers the parallel process for medicines rather than devices, and our guide to SEZ and EPZ manufacturing incentives is worth reading alongside this one for distributors who also plan to manufacture locally. Contact our Life Sciences & Healthcare practice to discuss structuring a compliant distribution business from the outset.
Sources: Pharmacy and Poisons Act (Cap. 244), as revised; Pharmacy and Poisons Board, Guidelines for Good Storage and Distribution Practices for Health Products and Technologies in Kenya; Pharmacy and Poisons Board, Guidelines for Registration and Licensing of Premises.
Frequently asked questions
Do I need a separate licence for every warehouse or branch?
Yes. Premises licensing under the Pharmacy and Poisons Act is granted per site, so a distributor operating storage facilities in more than one location needs a licence for each one rather than a single licence covering the whole business.
Is a device already approved by the FDA or in the EU automatically allowed into Kenya?
No. Foreign approval is useful supporting evidence in a Kenyan application and can make the PPB’s review faster, but it does not substitute for Kenya’s own Market Authorisation process, which every device needs before it can be marketed here.
Who needs to oversee a medical device wholesale business day to day?
Where the business involves a Wholesale Dealer’s Licence, a registered pharmacist who is resident in Kenya must be responsible for the operation. This is a named oversight requirement, not a box-ticking formality.
What happens if my premises licence lapses without me noticing?
Since the licence expires on 31 December each year, a distributor that misses renewal is technically operating unlicensed premises from 1 January until the licence is reinstated, which exposes the business to the same penalties as never having been licensed at all. Building renewal into the compliance calendar well before year end avoids this.
